Rangeley Capital »

Boundless Bio shares owned by Rangeley Capital

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $185k 74k 2.50

More positions owned by Rangeley Capital

Driven Brands Hldgs (DRVN)
Revolution Medicines *w Exp 12/17/202 (RVMDW)
Prothena Corp SHS (PRTA)
Seaport Entmt Group Common Stock (SEG)
Grindr (GRND)
Star Hldgs Shs Ben Int (STHO)
Full House Resorts (FLL)
Arbutus Biopharma (ABUS)
Tripadvisor (TRIP)
Echostar Corp Cl A
Abivax Sa Sponsored Ads (ABVX)
Green Dot Corp Cl A (GDOT)
Lawson Products (DSGR)
Theravance Biopharma (TBPH)
Rallybio Corp (RLYB)

View all positions for Rangeley Capital

Top funds holding Boundless Bio

Arch Venture Corp
FMR
Tang Capital Management
ADAR1 Capital Management
Cormorant Asset Management
Vanguard Capital Management
Wellington Management Company
Millennium Management
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Stonepine Capital Management
Acadian Asset Management

View all funds holding Boundless Bio